These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 35615049)

  • 1. The COVID-19 Impact and Culture Nexus in Japan: Insights for the Global Community.
    Pratt CB; Carr RL
    Front Public Health; 2022; 10():879653. PubMed ID: 35615049
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.
    Kinoshita R; Arashiro T; Kitamura N; Arai S; Takahashi K; Suzuki T; Suzuki M; Yoneoka D
    Emerg Infect Dis; 2023 Sep; 29(9):1868-1871. PubMed ID: 37506681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter from Japan: Re-thinking our future.
    Hashimoto S; Hikichi M; Maruoka S; Gon Y
    Respirology; 2021 Feb; 26(2):208-209. PubMed ID: 33295008
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan.
    Nakagawa S; Katayama T; Jin L; Wu J; Kryukov K; Oyachi R; Takeuchi JS; Fujisawa T; Asano S; Komatsu M; Onami JI; Abe T; Arita M
    Genes Genet Syst; 2023 Nov; 98(5):221-237. PubMed ID: 37839865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Investigation of SARS-CoV-2 in a Karaoke Bar: a Survey for a Cluster of COVID-19 in Hokkaido, Japan, 2020.
    Miyoshi M; Komagome R; Yamaguchi H; Yoshizumi S; Ishida S; Nagano H; Katamoto K; Okubo K; Goto A; Mitsuhashi K; Tanaka H; Shibata K; Shibuma T; Yamaya S; Tsuda S; Kuzuma A; Sadamoto T; Ohara T; Yamano K
    Jpn J Infect Dis; 2021 Sep; 74(5):495-497. PubMed ID: 33642436
    [No Abstract]   [Full Text] [Related]  

  • 6. Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan?
    Kaku N; Ota K; Sasaki D; Akamatsu N; Uno N; Sakamoto K; Kosai K; Hasegawa H; Izumikawa K; Mukae H; Yanagihara K
    Microbes Infect; 2021; 23(4-5):104812. PubMed ID: 33781868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020.
    Morikane K; Satoh N; Hatano K; Kanouchi K; Kakehata S; Satoh S; Uyeki TM; Ueno Y
    Western Pac Surveill Response J; 2021; 12(1):69-71. PubMed ID: 34094628
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan.
    Horita N
    Eur J Cancer; 2022 Apr; 165():113-115. PubMed ID: 35231766
    [No Abstract]   [Full Text] [Related]  

  • 9. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
    Yamayoshi S; Iwatsuki-Horimoto K; Okuda M; Ujie M; Yasuhara A; Murakami J; Duong C; Hamabata T; Ito M; Chiba S; Kobayashi R; Takahashi S; Mitamura K; Hagihara M; Shibata A; Uwamino Y; Hasegawa N; Ebina T; Izumi A; Kato H; Nakajima H; Sugaya N; Seki Y; Iqbal A; Kamimaki I; Yamazaki M; Kawaoka Y; Furuse Y
    Emerg Infect Dis; 2022 Nov; 28(11):2198-2205. PubMed ID: 36198306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of wastewater SARS-CoV-2 load with confirmed COVID-19 cases at a university hospital in Sapporo, Japan during the period from February 2021 to February 2023.
    Kagami K; Kitajima M; Takahashi H; Teshima T; Ishiguro N
    Sci Total Environ; 2023 Nov; 899():165457. PubMed ID: 37499823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the early stage of the coronavirus disease 2019 pandemic on surgical volume in Japan.
    Okuno T; Takada D; Shin JH; Morishita T; Itoshima H; Kunisawa S; Imanaka Y
    Br J Surg; 2021 Apr; 108(4):e173-e174. PubMed ID: 33793774
    [No Abstract]   [Full Text] [Related]  

  • 12. Nosocomial SARS-CoV-2 Infections in Japan: A Cross-sectional Newspaper Database Survey.
    Tani Y; Sawano T; Kawamoto A; Ozaki A; Tanimoto T
    Int J Health Policy Manag; 2020 Oct; 9(10):461-463. PubMed ID: 32610801
    [No Abstract]   [Full Text] [Related]  

  • 13. Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Matsumura Y; Nagao M; Yamamoto M; Tsuchido Y; Noguchi T; Shinohara K; Yukawa S; Inoue H; Ikeda T
    Emerg Infect Dis; 2022 Aug; 28(8):1569-77. PubMed ID: 35710464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID lessons from Japan: the right messaging empowers citizens.
    Oshitani H
    Nature; 2022 May; 605(7911):589. PubMed ID: 35606523
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: A large multicenter study in Japan.
    Yan Y; Tomooka K; Naito T; Tanigawa T
    J Infect Chemother; 2022 May; 28(5):709-713. PubMed ID: 35115238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.
    Fujino T; Nomoto H; Kutsuna S; Ujiie M; Suzuki T; Sato R; Fujimoto T; Kuroda M; Wakita T; Ohmagari N
    Emerg Infect Dis; 2021 Apr; 27(4):1243-5. PubMed ID: 33567247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system.
    Karako K; Song P; Chen Y; Karako T
    J Glob Health; 2022 Oct; 12():03073. PubMed ID: 36227719
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan.
    Cheng HY; Akhmetzhanov AR; Dushoff J
    Emerg Infect Dis; 2024 Jan; 30(1):206-207. PubMed ID: 38146985
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).
    Maeda H; Saito N; Igarashi A; Ishida M; Terada M; Ito T; Ikeda H; Kamura H; Motohashi I; Kimura Y; Komino M; Arai H; Kuwamitsu O; Akuzawa N; Sando E; Morikawa T; Imura H; Inoue H; Hayakawa T; Teshigahara O; Ohara Y; Suzuki M; Morimoto K
    Expert Rev Vaccines; 2023; 22(1):288-298. PubMed ID: 36883371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Ogata T; Tanaka H
    Emerg Infect Dis; 2024 Jan; 30(1):207. PubMed ID: 38146992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.